Health-related quality of life of primary care patients with depressive disorders by Riihimaki, K. et al.
European Psychiatry 37 (2016) 28–34Original article
Health-related quality of life of primary care patients with depressive
disorders
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A B S T R A C T
Background: Depressive disorders are known to impair health-related quality of life (HRQoL) both in the
short and long term. However, the determinants of long-term HRQoL outcomes in primary care patients
with depressive disorders remain unclear.
Methods: In a primary care cohort study of patients with depressive disorders, 82% of 137 patients were
prospectively followed up for five years. Psychiatric disorders were diagnosed with SCID-I/P and SCID-II
interviews; clinical, psychosocial and socio-economic factors were investigated by rating scales and
questionnaires plus medical and psychiatric records. HRQoL was measured with the generic 15D
instrument at baseline and five years, and compared with an age-standardized general population
sample (n = 3707) at five years.
Results: Depression affected the 15D total score and almost all dimensions at both time points. At the end
of follow-up, HRQoL of patients in major depressive episode (MDE) was particularly low, and the
association between severity of depression (Beck Depression Inventory [BDI]) and HRQoL was very
strong (r = 0.804). The most significant predictors for change in HRQoL were changes in BDI and Beck
Anxiety Inventory (BAI) scores. The mean 15D score of depressive primary care patients at five years was
much worse than in the age-standardized general population, reaching normal range only among
patients who were in clinical remission and had virtually no symptoms.
Conclusions: Among depressive primary care patients, presence of current depressive symptoms
markedly reduces HRQoL, with symptoms of concurrent anxiety also having a marked impact. For HRQoL
to normalize, current depressive and anxiety symptoms must be virtually absent.
 2016 Elsevier Masson SAS. All rights reserved.
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Depression is a major public health problem and known to cause
distress and disability [1,2]. It has also been found to be associated
significantly with decreased health-related quality of life (HRQoL) in
both general population [3–6] and primary care studies [2,7–
13]. Primary care patients with depressive symptoms have had
worse HRQoL than patients with common chronic medical
conditions and physical functioning in the midrange [2,8,12].
Convergently, in a study of secondary level psychiatric care patients,
HRQoL, assessed by the 15D instrument, was found to be lowest in* Corresponding author: Department of Psychiatry, Faculty of Medicine,
University of Helsinki, Helsinki University Hospital, P.O. Box 22, 00014 Helsinki,
Finland. Tel.: +358 9 471 63728; fax: +358 9 471 63735.
E-mail address: erkki.isometsa@hus.fi (E. Isometsä).
http://dx.doi.org/10.1016/j.eurpsy.2016.04.008
0924-9338/ 2016 Elsevier Masson SAS. All rights reserved.patients with depression relative to five common physical
conditions (operative treatment of cataract, operative treatment
of cervical or lumbar radicular pain, hysterectomy due to benign
uterine conditions, hip or knee replacement surgery, coronary
angiography due to suspected coronary artery disease) before
elective treatment [14]. Thus, there is little doubt that HRQoL is
impaired among individuals suffering from depression, irrespective
of setting, and is typically worse than among subjects suffering from
chronic physical diseases. However, the degree to which this is
caused by depression or reflects clustering of disorders or adversity
among individuals with depression remains less clear.
Although the epidemiological association between low HRQoL
and depression is unequivocal, there are key areas of uncertainty
that have major implications for health care. Establishing the
precise relationship between severity, duration and unique course
of depressive syndromes and HRQoL would help untangle the
K. Riihimäki et al. / European Psychiatry 37 (2016) 28–34 29effects of depression, somatic illness and other psychosocial
adversity linked to the condition. This would be especially
important in focusing treatment and support in primary health
and social care.
Depressive disorders are also known to be highly comorbid
both in the general population [15,16] and primary care patients
[17], so in theory, poor HRQoL may well be a result of multiple co-
occurring syndromes rather than depression alone. In particular,
anxiety disorders are known to affect HRQoL negatively [3,18]. Fur-
thermore, many risk factors for depression, such as poor social
support or stressful life conditions, may themselves predispose to
poor HRQoL, but remain often partly or fully unmeasured in
studies, and the association with depression could thus be partly a
matter of co-occurrence rather than causal. However, current
literature is largely unable to answer these questions.
Our aim was to investigate HRQoL and its predictors for change
within a prospective Finnish cohort study of primary care patients
with depressive disorders. We hypothesized that between-subject
differences in HRQoL would correlate with severity and change of
symptoms of depression and duration of depressive episodes as
well as concurrent anxiety. Furthermore, we hypothesized that
intraindividual change in HRQoL would be predicted by duration of
depression and change in concurrent depressive and anxiety
symptoms. We also explored the associations with other clinical
and psychosocial factors. Furthermore, to determine whether
remission from depression would normalize HRQoL, we compared
HRQoL of depressive primary care patients with that of an age-
standardized sample of the Finnish general population.
2. Methods
2.1. Patients and procedures of the Vantaa Primary Care Depression
Study
The Vantaa Primary Care Depression Study (PC-VDS) was
approved by the pertinent Ethics Committee in 2001. Details of
methodology of the PC-VDS have been published elsewhere
[17,19]. In brief, based on stratified sampling within the city of
Vantaa, Finland, altogether 373 of 1119 general practitioners’
patients aged 20–69 years screened with the Primary Care
Evaluation of Mental Disorders (PRIME-MD) [20] had a positive
screen for depression [17]. The presence of at least one core
symptom of major depressive disorder (MDD) according to the
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I/P)
[21] was confirmed by telephone. All of the 175 potentially eligible
patients were interviewed face-to-face using the SCID I/P with
psychotic screen. Inclusion criteria were current: MDD, dysthymia,
subsyndromal MDD with two to four depression symptoms
(minimum one core symptom) and lifetime MDD and minor
depression otherwise similar to subsyndromal MDD, but without
MDD history. Patients who refused to participate (15%) did not
differ significantly in age or gender from those who consented. The
diagnostic reliability for current depressive disorder diagnoses was
excellent (kappa = 1.0) [17].
The final study sample comprised 137 patients. Current and
lifetime psychiatric disorders were assessed with SCID-I/P and
SCID-II interviews [21,22]. In addition to the face-to-face inter-
views, observer- and self-report scales and all medical and
psychiatric records were used to assess retrospective and
prospective course of depression, comorbid disorders and psycho-
social and socioeconomic factors [17]. Scales comprised Hamilton
Rating Scale for Depression (HAMD) [23], Beck Depression
Inventory (BDI) [24], Beck Anxiety Inventory (BAI) [25], Beck
Hopelessness Scale (HS) [26], Social and Occupational Functioning
Assessment Scale for DSM-IV (SOFAS) [27], Scale for Suicidal
Ideation (SSI) [28] and Perceived Social Support Scale - Revised(PSSS-R) [29]. Personality was assessed by EPI-Q [30], a short
measure based on Eysenck Personality Inventory, form B (EPI) [31].
After baseline, patients were prospectively investigated at 3,
6 and 18 months and 5 years [19]. The 5-year investigation
included the same diagnostic interviews, scales and medical and
psychiatric records as the baseline investigation. Timing and
duration of episodes of depression and substance abuse were
integrated into a graphic life-chart. The time after the baseline
interview was divided into three categories: state of MDE (five or
more of the nine criteria symptoms); partial remission (one to four
symptoms); or full remission (no symptoms).
Drop-outs (18%) did not differ from participants in age, gender,
baseline depression severity [19] or 15D score. At baseline, 88%
(121/137) of all patients and 95% (106/111) of patients followed up
for 5 years filled in the 15D questionnaire. Altogether 68% (93/137)
of patients who had filled in the 15D questionnaire at both time
points were included in the longitudinal regression analyses.
Patient characteristics are shown in Table 1. The results are based
on our whole sample of patients with depressive disorders.
2.2. Health-related quality of life
Health-related quality of life (HRQoL) was measured at baseline
and at 5 years with a generic, self-report and preference-based
HRQoL measure: the 15D, which can be used as a profile and a
single index utility score measure. The 15D questionnaire is
composed of 15 dimensions with five levels of severity: mobility,
vision, hearing, breathing, sleeping, eating, speech (communica-
tion), excretion, usual activities, mental function, discomfort and
symptoms, depression, distress, vitality and sexual activity. The
single index score (15D score), representing the overall HRQoL on a
0–1 scale (1 = full health, 0 = being dead), and the dimension level
values, reflecting the goodness of the levels relative to no problems
on the dimension (= 1) and to being dead (= 0), are calculated from
the questionnaire by using a set of population-based preference or
utility weights [32]. The minimum clinically important change or
difference in the 15D score is  0.015 [33]. With regard to the
important properties (reliability, validity, discriminatory power,
responsiveness to change), the 15D performs at least equally to the
other preference-based generic instruments [32,34–37]. At baseline,
Cronbach’s alpha coefficient for the 15D was 0.870.
2.3. National Health 2011 Survey
For purposes of this study, the 15D data of the general
population came from the National Health 2011 Survey and
represented the Finnish population aged 18 years and over
[38]. For this analysis, individuals in the age range of the patients
were selected (n = 3707). This sample was weighted to reflect the
age distribution of the patients. The mean 15D scores and
dimension level values (15D profiles) of our patients and of age-
standardized population are shown in Table 2 and Fig. 1.
2.4. Statistical methods
Between-group comparisons were carried out using the Chi2
test statistic with Yates’ continuity correction or Fisher’s exact test,
the two-sample t-test or ANOVA, and the Mann–Whitney and
Kruskal–Wallis tests as appropriate. Bivariate correlational anal-
yses and linear regression models were used to analyse
associations of different variables with HRQoL. In multivariate
models, variables were included based on our hypotheses. The
predetermined independent variables at baseline comprised
HAMD (alternatively BDI), history of former MDE, BAI, HS, SSI,
SOFAS, PSSS-R, EPI-Q, psychiatric and medical comorbidity, and
marital, educational, occupational and economic status. In final
Table 1
Characteristics of patients in the Vantaa Primary Care Depression Study (n = 93).
Variable At baseline At five years Change
n % n %
Socio-demographic features
Male gender 19 20.4
Cohabiting 48 51.6 46 49.5
Employed 51 54.8 46 49.5
Unemployed 17 18.3 10 10.8
Professional education, any 60 64.5
Mean SD Mean SD
Age (years) 43.7 13.5
n % n %
Clinical features
Anxiety disorder (any) 44 47.3 47 50.5
Generalized anxiety disorder 14 15.1 14 15.1
Panic disorder 6 6.5 9 9.7
Social phobia 17 18.3 16 17.2
Personality disorder 50 53.8 43 46.2
Cluster B 28 30.1 24 25.8
Cluster C 32 34.4 32 34.4
Substance use disorder 12 12.9 9 9.7
Physical illness interfered with everyday life 40 43.0 50 53.8
Mean SD Mean SD Mean SD
Hamilton Rating Scale for Depression 16.3 5.6 11.4 7.9 4.9 7.2
Beck Depression Inventory 19.3 10.3 14.6 11.0 4.7 9.8
Time spent in MDE during follow-up (months) – – 21.0 22.4 – –
Beck Anxiety Inventory 17.5 12.6 13.5 12.0 4.0 12.7
Beck Hopelessness Scale 8.3 5.2 7.7 5.5 0.5 4.7
Scale for Suicidal Ideation 2.9 5.8 1.9 4.7 1.0 6.6
Perceived Social Support Scale - Revised 44.0 12.5 46.8 13.0 2.5 11.7
Functional and work ability
Social and Occupational Functioning Assessment Scale 57.4 11.4 64.6 15.9 7.0 4.7
Off work due to depression during follow-up (months) – – 15.3 24.0 – –
Personality
Neuroticism 6.6 2.0 5.8 2.4
Extraversion 4.1 2.0 3.5 2.4
Health-related quality of life, 15D score 0.775 0.124 0.818 0.124 0.044 0.123
Mobility (Move) 0.939 0.124 0.924 0.142 0.014 0.155
Vision (See) 0.952 0.115 0.916 0.162 0.036 0.167
Hearing (Hear) 0.951 0.108 0.939 0.145 0.012 0.132
Breathing (Breath) 0.809 0.247 0.877 0.188 0.068 0.230
Sleeping (Sleep) 0.637 0.257 0.724 0.226 0.087 0.233
Eating (Eat) 0.996 0.037 0.992 0.052 0.004 0.064
Speech (Speech) 0.949 0.120 0.925 0.154 0.025 0.169
Excretion (Excret) 0.779 0.195 0.820 0.197 0.041 0.237
Usual activities (Uact) 0.739 0.228 0.787 0.264 0.049 0.271
Mental Function (Mental) 0.685 0.226 0.747 0.247 0.062 0.278
Discomfort and symptoms (Disco) 0.629 0.260 0.684 0.239 0.055 0.248
Depression (Depr) 0.574 0.210 0.733 0.226 0.159 0.255
Distress (Distr) 0.616 0.228 0.716 0.241 0.100 0.239
Vitality (Vital) 0.576 0.223 0.689 0.219 0.113 0.247
Sexual activity (Sex) 0.720 0.262 0.735 0.294 0.015 0.341
K. Riihimäki et al. / European Psychiatry 37 (2016) 28–3430models, the non-significant (P > 0.05) variables were omitted. All
models were adjusted for age and gender, and when appropriate,
also for follow-up time, severity of depression and duration of
MDEs. To estimate the influence of current depressive state on the
variance in the 15D score, we conducted separate sensitivity
analyses of patient subgroups in full remission, in partial remission
or in MDE at 5 years. Statistical package for the social sciences
(SPSS Inc., USA), version 23, was used.
3. Results
3.1. Health-related quality of life among depressive primary care
patients
The mean 15 score with its dimensions at baseline and at
5 years and the mean changes in the scores during the follow-upare shown in Table 1. The mean change of the 15D score was 0.044
(median 0.031, SD: 0.123, min 0.29, max 0.47). The 15D score
deteriorated in 37% (34/93) and improved in 63% (59/93) of
patients.
3.2. Cross-sectional associations between HRQoL and depressive and
other symptoms and factors
At the time of the baseline interview, the 15D score was
strongly associated with depression, anxiety and many other
variables; correlations of all dimensions at baseline are presented
in Table 3a. At the end of the five-year follow-up, the current
severity of depression was very strongly associated with the 15D
score irrespective of whether the correlation was with BDI
(r = 0.804) or HAMD (r = 0.764) (Table 3b). The 15D score of
patients in MDE was particularly low (mean 15D score: 0.679)
Table 2
Mean 15D scores, dimension level values and psychiatric symptom scores in full
remission (FR), in partial remission (PR), and in major depressive episode (MDE) at







Mean Mean Mean P
15D score 0.887 0.821 0.679 < 0.001
Mobility (Move) 0.943 0.928 0.854 0.053
Vision (See) 0.954 0.914 0.871 0.109
Hearing (Hear) 0.929 0.976 0.902 0.116
Breathing (Breath) 0.941 0.834 0.775 0.001
Sleeping (Sleep) 0.833 0.701 0.551 < 0.001
Eating (Eat) 0.986 1.000 1.000 0.326
Speech (Speech) 0.947 0.951 0.860 0.046
Excretion (Excret) 0.831 0.834 0.752 0.221
Usual activities (Uact) 0.892 0.786 0.533 < 0.001
Mental function (Mental) 0.852 0.743 0.581 < 0.001
Discomfort and symptoms (Disco) 0.761 0.702 0.498 < 0.001
Depression (Depr) 0.877 0.749 0.437 < 0.001
Distress (Distr) 0.836 0.744 0.482 < 0.001
Vitality (Vital) 0.823 0.670 0.445 < 0.001
Sexual activity (Sex) 0.814 0.792 0.576 0.003
Psychiatric symptoms
Beck Depression Inventory 6.6 15.0 30.6 < 0.001
Hamilton Rating Scale for Depression 5.1 12.3 23.1 < 0.001
Beck Anxiety Inventory 6.7 13.7 27.3 < 0.001
ANOVA.
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the current state of depression (full remission, partial remission or
MDE) (Table 2). Only one of the 15 dimensions (eating) was not
associated with depression (Tables 3a–c).
3.3. Baseline predictors for health-related quality of life at five-year
follow-up among depressive primary care patients
Many variables predicted HRQoL after five years. In univariate
linear regression, adjusted for age and gender, the following
baseline variables were significant predictors for better HRQoL at
5 years: younger age (P = 0.004), higher professional education
(P < 0.001), economic situation (not receiving welfare benefit,
P < 0.001), non-smoking (P = 0.010), lower BDI (P < 0.001), HAMD
(P < 0.001), BAI (P < 0.001), HS (P = 0.007) and SSI (P = 0.020),
higher SOFAS (P = 0.011), less panic disorder (P < 0.001), somato-
form disorder (P = 0.017), personality disorder cluster B (P = 0.003),
borderline personality disorder (P = 0.001), substance use disorder
(P = 0.001) and alcohol abuse or dependence (P = 0.030), and less








Fig. 1. Mean 15D profiles and 15D scores of all Vantaa Primary Care Depression Study p
n = 50), in partial remission (PartRem, n = 35) and in MDE (MDE, n = 21) at five years, aHowever, not all of these variables were independent predictors
of HRQoL. In the final multivariate analyses for HRQoL at 5 years
(adjusted for age and gender), younger age (0.003 [95% CI:
0.005–0.002]; P < 0.001), higher professional education
(0.076 [95% CI: 0.035–0.118]; P < 0.001), lower BDI (0.003
[95% CI: 0.005–0.001]; P = 0.001), less substance use (0.063
[95% CI: 0.121–0.001]; P = 0.034) and less panic disorder
(0.082 [95% CI: 0.163–0.002]; P = 0.044) remained significant
predictors of better HRQoL (R2 = 0.428, adjusted R2 = 0.393).
When time spent in MDEs during follow-up was included
(adjusted for age, gender and follow-up time), significant
predictors of better HRQoL were younger age (0.003 [95% CI:
0.004–0.001]; P < 0.001), less time spent in MDEs during
follow-up (0.003 [95% CI: 0.004–0.002]; P < 0.001) and higher
professional education (0.089 [95% CI: 0.053–0.125]; P < 0.001)
(R2 = 0.514, adjusted R2 = 0.495). However, time spent in MDEs
(P = 0.272) did not predict HRQoL, when adjusted for current BDI
(P < 0.001) or current HAMD (P < 0.001).
3.4. Predictors for change in health-related quality of life during the
five-year follow-up among depressive primary care patients
Significant bivariate correlations between changes in the 15D
variables and changes in other variables during the five-year
follow-up are presented in Table 3c.
In univariate linear regression, significant predictors of an
improvement in HRQoL were a decrease in the HAMD, BDI, BAI, HS
and SSI scores. Time spent in MDEs during follow-up was not
associated with an improvement in HRQoL. In multivariate linear
regression analyses, only a decrease in the BDI and BAI scores
remained significant predictors of an improvement in HRQoL
(Table 4).
3.5. Health-related quality of life of depressive primary care patients
vs the general population
At the end of the 5-year follow-up, the mean 15D scores and
profiles of patients in MDD and partial or full remission, compared
with an age-standardized sample of the general population, are
presented in Fig. 1. HRQoL of depressive primary care patients
differed from that of the general population even among patients
reaching full clinical remission, and all but one dimension of the
15D (eating) differed significantly from the general population.
We conducted a further analysis of the role of mild residual
symptoms among clinically remitted patients. In a multivariate
regression analysis within this population, the variation in BDI
(0.004 [95% CI: 0.007–0.001]; P = 0.014) and BAI (0.003 [95%Populatio n




Mean 15 D scor e
Populatio n 0.93 7
All patien ts 0.82 4
Full rem iss ion 0.88 7
Parti al remi ssion 0.82 1
MDE  0.67 9
atients (All patients, n = 106) and separately for patients in full remission (FullRem,
nd those of an age-standardized sample of the general population (Population).
Table 3a
Significant bivariate Pearson correlations of the 15D variables and other variables at baseline in the Vantaa Primary Care Depression Study (n = 121).
15D score Move See Hear Breath Sleep Eat Speech Excret Uact Mental Disco Depr Distr Vital Sex
Beck Depression Inventory 0.644** 0.226* 0.214* 0.385** 0.345** 0.454** 0.523** 0.519** 0.692** 0.617** 0.632** 0.497**
Hamilton Rating Scale for
Depression
0.576** 0.280** 0.298** 0.479** 0.401** 0.442** 0.510** 0.564** 0.475** 0.581** 0.509**
Beck Anxiety Inventory 0.751** 0.294** 0.234** 0.200* 0.585** 0.494** 0.285** 0.342** 0.462** 0.619** 0.622** 0.570** 0.661** 0.605** 0.477**
Beck Hopelessness Scale 0.487** 0.216* 0.376** 0.252** 0.184* 0.180* 0.217* 0.423** 0.328** 0.523** 0.384** 0.476** 0.370**




0.447** 0.297** 0.255** 0.269** 0.192* 0.183* 0.217* 0.284** 0.377** 0.408* 0.394** 0.263** 0.299** 0.430**
Perceived Social Support
Scale-R
0.340** 0.208* 0.327** 0.336** 0.211** 0.323** 0.222* 0.294** 0.221*
Anxiety disorder, any 0.248** 0.209* 0.185* 0.233* 0.285** 0.210*




Significant Pearson bivariate correlations between the 15D variables and other variables in the Vantaa Primary Care Depression Study at five years (n = 106).
15D score Move See Hear Breath Sleep Eat Speech Excret Uact Mental Disco Depr Distr Vital Sex
15D 1 0.486** 0.531** 0.327** 0.623** 0.632** 0.445** 0.478** 0.721** 0.687** 0.700** 0.746** 0.714** 0.789** 0.610**
Beck Depression Inventory 0.804** 0.263** 0.397** 0.442** 0.547** 0.275** 0.351** 0.548** 0.533** 0.524** 0.851** 0.707** 0.773** 0.492**
Hamilton Rating Scale for Depression 0.764** 0.276** 0.330** 0.403** 0.571** 0.267** 0.270** 0.537** 0.524** 0.524** 0.763** 0.604** 0.759** 0.456**
Beck Anxiety Inventory 0.718** 0.276** 0.407** 0.345** 0.470** 0.216* 0.481** 0.430** 0.522** 0.559** 0.656** 0.705** 0.636** 0.344**
Beck Hopelessness Scale 0.537** 0.303** 0.385** – 0.267** 0.356** 0.356** 0.334** 0.709** 0.609** 0.553** 0.343**
Scale for Suicidal Ideation 0.417** 0.199* 0.237* 0.196* 0.311** 0.213** 0.262** – 0.246* 0.219* 0.495** 0.410** 0.414** 0.304**
Social and Occupational
Functioning Assessment Scale
0.638** 0.294** 0.274** 0.361** 0.347** 0.271** 0.563** 0.484** 0.408** 0.531** 0.414** 0.592** 0.453**
Perceived Social Support Scale-R 0.408** 0.222* 0.345** 0.343** 0.260** 0.278** 0.204* 0.445** 0.496** 0.298** 0.275**
Anxiety disorder, any 0.315** 0.279** 0.209* 0.217* 0.330** 0.210* 0.264** 0.360** 0.365** 0.266**
Generalized anxiety disorder 0.213* 0.193* 0.201* 0.248* 0.237* 0.318**
Panic disorder 0.334** 0.194* 0.299**
Social phobia 0.199* 0.291** 0.259** 0.243*
Substance use disorder 0.300** 0.207* 0.219* 0.245* 0.281** 0.351** 0.355** 0.228*
Alcohol Use Disorders Identification
Test
0.218* 0.255** 0.325**
Time spent in Major Depressive
Episodes BL-5y
0.585** 0.276** 0.200* 0.278** 0.379** 0.199* 0.556** 0.369** 0.314** 0.595** 0.535** 0.472** 0.445**
Time spent unable to work due to
depression BL-5y
0.197* 0.220* 0.263** 0.223* 0.217*
Duration of sick leaves due to
depression BL-5y
0.364** 0.279* 0.339** 0.398** 0.290* 0.300* 0.271* 0.410**
Disability pension due to depression 0.328** 0.201* 0.318** 0.251** 0.270** 0.276** 0.263** 0.242* 0.376**









































Significant bivariate Pearson correlations between changes in the 15D variables and changes in other variables during the five-year follow-up in the Vantaa Primary Care
Depression Study (n = 93).
15D score Move See Hear Breath Sleep Eat Speech Excret Uact Mental Disco Depr Distr Vital Sex
Beck Depression Inventory .624** .389** .343** .317** .354** .457** .299** .609** .561** .513** .514**
Hamilton Rating Scale for
Depression
.415** .320** .337** .286** .319** .386** .252** .432** .327**
Beck Anxiety Inventory .610** .279** .424** .304** .399** .308** .493** .458** .401** .436** .538** .300**
Beck Hopelessness Scale .452** .227* .343** .247* .311** .447** .434** .462** .295**




.375** .308** .317** .406** .254* .268** .269** .326**
Perceived Social Support
Scale R
.289** .237* .235* .252* .239* .286* .282** .291**
* P < 0.050.
** P < 0.010.
Table 4
Multivariate linear regression for the change in health-related quality of life
(change in 15D score) during follow-up in the Vantaa Primary Care Depression
Study (n = 93).
B 95% CI P
Age 0.001 0.002–0.000 0.160
Gender 0.020 0.067–0.026 0.382
Beck Depression Inventory, change 0.005 0.007–0.003 < 0.001
Beck Anxiety Inventory, change 0.004 0.006–0.002 < 0.001
R2 = 0.513, adjusted R2 = 0.491.
K. Riihimäki et al. / European Psychiatry 37 (2016) 28–34 33CI: 0.005–0.000]; P = 0.022) significantly predicted HRQoL.
Among remitted patients (50/106) whose BDI and BAI scores
were < 6 (26%, 13/50), HRQoL reached the level of general
population scores (0.929); if both BDI and BAI scores were < 5
(16%, 8/50), HRQoL was very good (0.991).
4. Discussion
The HRQoL, measured by the 15D score, and almost all of the
dimension values were strongly related to the current severity of
depression in depressive primary care patients. The mean HRQoL
was particularly low among patients in MDE at the end of follow-
up, but even in clinically remitted patients it did not reach the
mean population score, unless the patients were virtually free of
residual symptoms of depression and anxiety. The adverse
influences of comorbid disorders, particularly anxiety but also
substance use, were significant. In addition, socio-demographic
factors, such as education, affect the HRQoL of patients with
depression.
This study has several major strengths. These include a
screened medium-sized cohort of depressive patients derived
from a stratified sampling of 1119 primary health attenders,
structured interviews with SCID-I/P and SCID-II by psychiatrists
and a longitudinal study design with a five-year follow-up and a
small drop-out rate. The life chart methodology enabled evaluation
of the longitudinal course of illness and time-related psychosocial
factors. Depressive disorders in this primary care cohort were
typically MDD of mild to moderate severity, usually recurrent or
chronic in nature [17,19]. Comprehensive clinical interviews
allowed us to analyse the influence of clinical symptoms and
other characteristics on HRQoL; use of life charts enabled
measurement of the time spent in different states of depression
during the preceding five years. In addition, we carefully evaluated
the presence of psychiatric comorbidity [17]. A major strength of
the study was also that the HRQoL of patients could be compared
with that of a representative and age-standardized sample of the
Finnish general population from the Health 2011 Study.
The findings should, however, be interpreted in light of some
methodological limitations. First, the sampling of the cohort wasbased on stratified screening of depression to ensure representa-
tiveness [17]. However, inclusion of consecutive patients with
depressive disorders unavoidably enriches chronicity, as longer
duration of depression increases the probability of becoming
recruited. Nevertheless, the sample accurately reflects characte-
ristics of actual patients and the actual workload of physicians.
Second, despite the moderate sample size, the number of patients
in some subgroups remained small, thus increasing risk of type II
errors. Third, the study was naturalistic and the treatment received
was not controlled. Fourth, generalizability of our findings remains
uncertain. Our study sample comprised urban and suburban
primary care patients, while the general population sample was
collected from the whole country. Finally, we investigated HRQoL
by using the 15D. Given consistency of findings between different
measures of HRQoL (Hawthorne et al., 2001; Mihalopoulos et al.,
2014), we expect our findings to be representative rather than
specific to the instrument used, but this remains to be verified.
Among our depressive primary care patients, HRQoL correlated
strongly with current severity of depressive symptoms. Two-thirds
of patients experienced an improvement in HRQoL during follow-
up. However, one-third of patients showed a deterioration in
HRQoL. This reflects the rather chronic and recurrent tendency of
depression among primary care patients. The HRQoL of our
patients in MDE at the end of follow-up was even worse than the
HRQoL of depressive patients in secondary care [14]. The change in
HRQoL during follow-up correlated strongly with changes in the
severity of depression and anxiety. These findings are consistent
with our hypothesis and also in accordance with earlier literature
[7,8,11,13]. Only few studies have taken into account the duration
of time spent in MDEs. We found HRQoL to be moderately related
to the time spent in depressive episodes during the preceding five
years. Thus, the most consistent relationship was between HRQoL
and current symptoms. The mean 15D score in remitted patients
approached, but did not quite reach the mean population score,
unless clinical remission was complete [3]. Within the remitted
subgroup, severity of the remaining mild residual symptoms of
depression was more strongly associated with HRQoL than the
duration of depression. Besides depression, severity of anxiety
symptoms was a significant explanatory factor. These findings are
highly relevant for clinical definitions of remission from depres-
sion [39,40], as it appears that patients must be virtually free of
residual symptoms for their HRQoL to normalize.
We set out to investigate whether the presence of psychiatric
comorbidity significantly influences HRQoL among patients with
depression and found that it does. Especially concurrent anxiety
was associated with poor HRQoL; the former result is consistent
with epidemiological findings pertaining to the adverse influence
of anxiety disorders on HRQoL [3,18]. This is of both theoretical and
practical significance, as individuals suffering from depressive
disorder both in the general population [15,16] and in primary care
K. Riihimäki et al. / European Psychiatry 37 (2016) 28–3434commonly suffer from concurrent psychiatric disorders and
somatic illnesses [17]. This clustering of illnesses and syndromes
needs to be elucidated in future studies. Furthermore, it appears
that remission of not only depression but also anxiety symptoms is
a precondition for HRQol to normalize in primary care patients
with depressive disorders. Finally, besides psychiatric symptoms,
other factors may affect HRQoL. Of the socio-demographic factors
explored, completed professional education was a significant
predictor of better HRQoL.
The 15D instrument showed a good responsiveness to change in
depression. BDI was a better predictor of HRQoL than HAMD, in line
with our earlier findings [19]. The subjective measurement scales
15D and BDI both seem to perform well as prognostic instruments.
BDI is easiest to use in everyday busy primary care practice, whereas
15D is useful also in patient groups beyond of psychiatric illnesses.
Apart from one dimension (i.e. eating), all dimensions of the 15D
were negatively affected by depression. Thus, the effects of
depression are wide-ranging. As a generic instrument, the 15D
with its dimensions is valuable in studying the health problems,
psychiatric and physical, caused by various diseases. This empha-
sizes the importance of the profile property of the 15D.
In conclusion, among depressive primary care patients, the
relationships between depression and concurrent anxiety and
HRQoL, measured by the 15D, were strong, even in primary care.
For HRQoL to normalize in clinical remission from depression,
virtually all symptoms of depression or anxiety must be absent.
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